About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
By
Javed Butler
10 Videos
0 views
August 21, 2018
Comments
1
Login to view comments.
Click here to Login
Featured Video
26:13
Lilly Diabetes
A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…
Feat.
B. Hirsch
Featured Video
26:13
Lilly Diabetes
A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…
Feat.
B. Hirsch
Recommended
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
49:21
Physicians Committee for Responsible Medicine
Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…
Feat.
T. J. Key
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
61:49
Obafemi Awolowo University
Management of Heart Failure
Feat.
O. A. Akinyele
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
23:35
Canadian Collaborative Research Network
Is Obesity Management the Next Frontier?
Feat.
A. Michael Lincoff
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
14:19
UChicago Medicine
S-QUAD Therapy and Beyond: HFpEF in 2024
Feat.
M. Belkin
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…
Feat.
G. Umpierrez
27:52
Top Ten Topics in Clinical Cardiology 2023
Medical Management of Diastolic Dysfunction: Does The Emperor Finall…
Feat.
S. Pinney
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
13:43
Stanford Medicine
What's the Ideal Therapy for Obesity?
Feat.
A. Yeoh
34:04
The Texas Heart Institute
Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
Feat.
G. Bakris
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
